-+ 0.00%
-+ 0.00%
-+ 0.00%

Cardiff Oncology: Q3 Earnings Snapshot

Barchart·11/12/2026 06:21:30
Listen to the news

SAN DIEGO (AP) — SAN DIEGO (AP) — Cardiff Oncology, Inc. (CRDF) on Thursday reported a loss of $8.9 million in its third quarter.

The San Diego-based company said it had a loss of 12 cents per share.

The results exceeded Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 14 cents per share.

The molecular diagnostic company posted revenue of $171,000 in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $113,000.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRDF at https://www.zacks.com/ap/CRDF